Nick has more than 20 years’ industry experience in life sciences, healthcare and capital markets worldwide, having led a range of international transactions and strategic projects including M&A, fundraising (more than £100 million to date), licensing, divestments and new business ventures. He is also CBO at Artios Pharma Ltd and his previous positions include senior corporate and business development roles at USUS Lifesciences Consulting, Vectura, SSL International (acquired by Reckitt Benckiser in 2010) and Protherics (acquired by BTG in 2008). He was also formerly a life sciences equity analyst at WestLB Panmure and a management consultant in life sciences at PA Consulting. Nick gained a PhD in Biochemistry from the University of Cambridge and a BSc in Biochemistry and Molecular Biology from the University of Leeds. Nick has more than 20 years’ industry experience in life sciences, healthcare and capital markets worldwide, having led a range of international transactions and strategic projects including M&A, fundraising (more than £100 million to date), licensing, divestments and new business ventures. He is also CBO at Artios Pharma Ltd and his previous positions include senior corporate and business development roles at USUS Lifesciences Consulting, Vectura, SSL International (acquired by Reckitt Benckiser in 2010) and Protherics (acquired by BTG in 2008). He was also formerly a life sciences equity analyst at WestLB Panmure and a management consultant in life sciences at PA Consulting. Nick gained a PhD in Biochemistry from the University of Cambridge and a BSc in Biochemistry and Molecular Biology from the University of Leeds.

fermentation